Swiss healthcare costs have already risen by 7.5% this year
Santésuisse – the umbrella group for Swiss health insurers – has warned that health care costs have already risen by 7.5% per capita in the first two months of 2023.
This content was published on
1 minute
Keystone-SDA/ac
Italiano
it
I costi della sanità svizzera sono già aumentati del 7,5% quest’anno
According to Santésuisse, rising drug costs and the large number of drugs prescribed are the main reasons for the rise in costs.
“The result will be a further increase in premiums,” says Verena Nold, director of the health insurers’ association in an interview with SonntagsBlick.
Nold is calling for treatments that have been shown to be of no benefit to be removed from the catalogue of services.
“If we want our system to be financeable in the long term, we must become more efficient. To achieve this, the cantons should apply strict criteria to hospitals and no longer allocate all the service mandates to every small hospital,” she said.
Health insurance premiums have jumped by an average of 6.6% between 2022 and 2023, in connection with the pandemic and catch-up effects. According to the Federal Office of Public Health (FOPH), the average premium for adults rose to CHF397.20 per month. The premium for young adults rose by 6.3% to CHF 279.90 per month while those for children rose by 5.5% to an average of CHF 105.
These rises are not sufficient to meet growing cost of healthcare, according to Nold.
“At some point, this will catch up with us. We should have already raised premiums by 10% by 2023,” she said.
Popular Stories
More
Workplace Switzerland
Meet the foreigners who make up a quarter of the Swiss population
What can be done to protect biodiversity in your country?
Swiss voters are set to decide on a people’s initiative calling for better protection of ecosystems in the country. Have your say on the September 22 vote.
FINMA imposes heavy penalties on private bank Mirabaud
This content was published on
The Swiss Financial Market Supervisory Authority has taken action against private bank Mirabaud & Cie,over money laundering.
Switzerland edges closer to stricter screening of foreign investments
This content was published on
Foreign investors are set to face greater scrutiny in Switzerland as one parliamentary chamber passes the so-called Lex China bill.
Increase in animal testing in Switzerland last year
This content was published on
Almost 600,000 animals were used in animal experiments in Switzerland in 2023 - an increase of 1.6% compared to the previous year.
Beleaguered Swiss watch industry calls for political support
This content was published on
The Swiss watch industry is going through difficult times as global demand declines and the strong franc piles on the pressure.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.